Overview

Topical Application of AS101 for the Treatment of Atopic Dermatitis

Status:
Terminated
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
Atopic Dermatitis is a chronic non contagious disease that causes itchy, inflamed skin. The purpose of this study is to evaluate the safety and efficacy of topical AS101 ointment for the treatment of Atopic dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
BioMAS Ltd
Treatments:
Ammonium trichloro(dioxoethylene-O,O'-)tellurate